Unlock stock picks and a broker-level newsfeed that powers Wall Street.
208.93
+3.64
+(1.77%)
As of 2:26:32 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 15 | 15 | 24 | 25 |
Avg. Estimate | 2.51 | 3.09 | 12.28 | 13.88 |
Low Estimate | 2.48 | 2.95 | 12.01 | 12.72 |
High Estimate | 2.61 | 3.32 | 12.67 | 14.96 |
Year Ago EPS | 2.31 | 2.65 | 10.12 | 12.28 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 14 | 13 | 23 | 23 |
Avg. Estimate | 12.91B | 14.72B | 59.36B | 64.21B |
Low Estimate | 12.77B | 14.35B | 57.2B | 61.02B |
High Estimate | 13.35B | 15.03B | 60.57B | 66.64B |
Year Ago Sales | 12.31B | 14.46B | 56.33B | 59.36B |
Sales Growth (year/est) | 4.91% | 1.75% | 5.38% | 8.16% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 2.26 | 2.66 | 2.92 | 2.12 |
EPS Actual | 2.31 | 2.65 | 3 | 2.16 |
Difference | 0.05 | -0.01 | 0.08 | 0.04 |
Surprise % | 2.37% | -0.39% | 2.82% | 1.92% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 2.51 | 3.09 | 12.28 | 13.88 |
7 Days Ago | 2.52 | 3.09 | 12.28 | 13.9 |
30 Days Ago | 2.52 | 3.08 | 12.26 | 13.81 |
60 Days Ago | 2.63 | 3.18 | 12.19 | 13.72 |
90 Days Ago | 2.62 | 3.18 | 12.18 | 13.65 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | 3 | 3 |
Up Last 30 Days | 1 | 1 | 7 | 6 |
Down Last 7 Days | -- | -- | 1 | -- |
Down Last 30 Days | 1 | -- | 3 | 3 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ABBV | 8.66% | 16.59% | 21.32% | 13.09% |
S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Upgrades & Downgrades
Maintains | Wells Fargo: Overweight to Overweight | 3/5/2025 |
Maintains | B of A Securities: Neutral to Neutral | 3/4/2025 |
Maintains | Citigroup: Buy to Buy | 2/3/2025 |
Maintains | Truist Securities: Buy to Buy | 2/3/2025 |
Maintains | UBS: Neutral to Neutral | 2/3/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 2/3/2025 |
Related Tickers
MRK Merck & Co., Inc.
89.17
-0.06%
PFE Pfizer Inc.
25.00
-0.83%
JNJ Johnson & Johnson
165.76
+1.25%
BMY Bristol-Myers Squibb Company
60.85
+1.37%
LLY Eli Lilly and Company
819.21
-0.40%
AMGN Amgen Inc.
310.95
+1.30%
NVO Novo Nordisk A/S
68.99
+1.16%
GILD Gilead Sciences, Inc.
111.39
-0.36%
GSK GSK plc
38.48
-0.68%
AZN AstraZeneca PLC
73.11
-0.92%